Assyro AI

FDA Orange Book · active-ingredient family

Tiotropium bromide

Tiotropium bromide is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SPIRIVA RESPIMAT · NDA 021936

2

Brand (NDA)

1

Generics (ANDA)

10

Listed patents

0

Exclusivity periods

Brand (NDA) products · powder, spray, metered

ProductApplicantApplicationTEApproved
SPIRIVA RESPIMATRLD×2BOEHRINGER INGELHEIMNDA 021936Sep 15, 2015
SPIRIVARLDBOEHRINGER INGELHEIMNDA 021395ABJan 30, 2004

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
TIOTROPIUM BROMIDELUPINANDA 211287ABJun 20, 2023

Listed patents (10)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8022082Jan 19, 20265 mo ago
ProductU-1186
8022082*PEDJul 19, 2026in 1 mo
7396341Oct 10, 2026in 4 mo
ProductDelisted
9027967Mar 31, 2027in 10 mo
ProductDelisted
7396341*PEDApr 10, 2027in 10 mo
9027967*PEDSep 30, 2027in 1 yr 4 mo
7837235Mar 13, 2028in 1 yr 9 mo
ProductDelisted
7837235*PEDSep 13, 2028in 2 yr 3 mo
8733341Oct 16, 2030in 4 yr 5 mo
ProductDelisted
8733341*PEDApr 16, 2031in 4 yr 11 mo

Tiotropium bromide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.